EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Radiotheranostics With Nanoparticles: Precision Targeting in Receptor‐Overexpressing Tumors

Evalyne J Cheruiyot, David M Wanjeh, John K Birir, Susan W Karuga, Beatrice K Amugune iD, Claudia G Chambers, Michael R Lewis, Charles J Smith, Tamer M Sakr iD

Journal of Labelled Compounds and Radiopharmaceuticals · 2026

DOI: 10.1002/jlcr.70028 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Labelled Compounds and Radiopharmaceuticals, 2026. Verfasst von Evalyne J Cheruiyot und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nuclear Science & Technology, University of Nairobi, Nairobi, Kenya. Hauptthemen laut MEDLINE: Neoplasms, Nanoparticles, Theranostic Nanomedicine, Radiopharmaceuticals. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 269 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains one of the most challenging medical conditions. Nanotechnology is revolutionizing the approach to cancer management as an efficient tool for early diagnosis, therapy and monitoring. Nanoparticles (NPs) have shown promising results in advancing precision medicine by integrating diagnostic imaging and targeted therapy within a single platform, a concept of theranostics. Nanocarriers are synthesized via the use of biocompatible materials that are functionalized with specific ligands that bind to receptors that are overexpressed on the surface of cancer cells. For theranostic purposes, these NPs are loaded with suitable radioisotopes that emit gamma, positron, alpha or beta radiation for imaging and/or therapy. Despite the significant successes, most of the work is still at the preclinical stages awaiting clinical translation. In this review, a comprehensive examination of the current state of receptor‐targeted radiotheranostic NPs is presented, with a focus on their design, functionalization, receptor‐specific targeting, and clinical translational potential. The role of key tumor markers is highlighted in guiding NP delivery and improving precision and therapy. The exploration of these cutting‐edge advancements and associated challenges will provide insights into the revolution of radiotheranostic nanomedicine and its impact on the future of precision oncology.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsNanoparticlesTheranostic NanomedicineRadiopharmaceuticalsPrecision MedicineHumansAnimals

Stichwörter der Autor:innen

cancer therapeuticsnanomedicinenanoparticlesprecision oncologyradiotheranosticsreceptor‐overexpressing tumorstargeted drug delivery

Substanzen

Radiopharmaceuticals

Autor:innen und Institutionen

  • Institute of Nuclear Science & Technology, University of Nairobi, Nairobi, Kenya.
  • Integrated Molecular Imaging Center, Kenyatta University, Teaching, Referral & Research Hospital, Nairobi, Kenya.
  • Department of Pharmacy, University of Nairobi, Nairobi, Kenya.
  • Department of Chemistry, University of Missouri, Columbia, Missouri, USA.
  • Molecular Imaging and Theranostics Center, University of Missouri, Columbia, Missouri, USA.
  • Research Service, Harry S. Truman Memorial Veterans' Hospital, Columbia, Missouri, USA.

ORCID-Profile: Beatrice K Amugune, Tamer M Sakr

Zitieren

APA

Cheruiyot, E. J., Wanjeh, D. M., Birir, J. K., Karuga, S. W., Amugune, B. K., Chambers, C. G., Lewis, M. R., Smith, C. J., & Sakr, T. M. (2026). Radiotheranostics With Nanoparticles: Precision Targeting in Receptor‐Overexpressing Tumors. Journal of Labelled Compounds and Radiopharmaceuticals. https://doi.org/10.1002/jlcr.70028

Vancouver

Cheruiyot EJ, Wanjeh DM, Birir JK, Karuga SW, Amugune BK, Chambers CG, et al. Radiotheranostics With Nanoparticles: Precision Targeting in Receptor‐Overexpressing Tumors. Journal of Labelled Compounds and Radiopharmaceuticals. 2026. doi:10.1002/jlcr.70028

BibTeX
@article{Cheruiyot2026,
  author = {Cheruiyot, Evalyne J and Wanjeh, David M and Birir, John K and Karuga, Susan W and Amugune, Beatrice K and Chambers, Claudia G and Lewis, Michael R and Smith, Charles J and Sakr, Tamer M},
  title = {Radiotheranostics With Nanoparticles: Precision Targeting in Receptor‐Overexpressing Tumors},
  journal = {Journal of Labelled Compounds and Radiopharmaceuticals},
  year = {2026},
  doi = {10.1002/jlcr.70028}
}
Kostenlos starten →